Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,107 public trials 1,861 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Enrolling by Invitation

The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery

NCT07125573

Conditions: Esketamine Plus Dexmedetomidine Affect Postoperative Quality, Lung Diseases, Lung Neoplasms, +6 more
Locations: First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China

View Trial Details

Enrolling by Invitation

Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)

NCT06391749

Conditions: Breast Diseases, Breast Neoplasms, Cancer Colon, +26 more
Locations: Medical Genetics Institute Ho Chi Minh City, Vietnam

View Trial Details

Enrolling by Invitation

The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery

NCT07060625

Conditions: Disease, Hypoxemia, Hypoxia, +12 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by Invitation

⁶⁸Ga-DPA in the Lung Cancer Diagnosis

NCT07023068

Conditions: Lung Cancers, Lung Diseases, Lung Neoplasms, +5 more
Locations: 100730 Beijing, China

View Trial Details

Enrolling by Invitation

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

NCT06997458

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations: Centre for Genomics and Oncological Research - Pfizer - University of Granada - Andalusian Regional Government (GENyO) Granada, Andalusia, Spain

View Trial Details

Enrolling by Invitation

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

NCT06419179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: University Hospital Cologne Cologne, North Rhine-Westphalia, Germany

View Trial Details

Enrolling by Invitation

Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer

NCT06962449

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by Invitation

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216

Conditions: Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China

View Trial Details

Enrolling by Invitation

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

NCT06883136

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Degan Lu Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Enrolling by Invitation

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

NCT06876675

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Peking University Third Hospital Beijing, China

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions